Home Healthcare Biotechnology Encephalitis Vaccines Market

Encephalitis Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type (Mouse brain-derived inactivated vaccine, Cell culture-derived inactivated vaccine, Cell culture-derived live attenuated vaccine), By Indication (Japanese encephalitis, Tick-borne encephalitis, Rabies encephalitis), By Age Group (Children, Adult) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Encephalitis Vaccines Market, By Vaccine Type 2022-2034 (USD MILLION/ Units)
    1. Mouse brain-derived inactivated vaccine
    2. Cell culture-derived inactivated vaccine
    3. Cell culture-derived live attenuated vaccine
  2. Encephalitis Vaccines Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Japanese encephalitis
    2. Tick-borne encephalitis
    3. Rabies encephalitis
  3. Encephalitis Vaccines Market, By Age Group 2022-2034 (USD MILLION/ Units)
    1. Children
    2. Adult
  4. Regional Encephalitis Vaccines Market
    1. North America
      1. North America Encephalitis Vaccines Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
      2. North America Encephalitis Vaccines Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Japanese encephalitis
        2. Tick-borne encephalitis
        3. Rabies encephalitis
      3. North America Encephalitis Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adult
      4. U.S.
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      5. Canada
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
    2. Europe
      1. Europe Encephalitis Vaccines Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
      2. Europe Encephalitis Vaccines Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Japanese encephalitis
        2. Tick-borne encephalitis
        3. Rabies encephalitis
      3. Europe Encephalitis Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adult
      4. U.K.
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      5. Germany
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      6. France
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      7. Spain
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      8. Italy
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      9. Russia
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      10. Nordic
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      11. Benelux
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      12. Rest of Europe
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
    3. APAC
      1. APAC Encephalitis Vaccines Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
      2. APAC Encephalitis Vaccines Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Japanese encephalitis
        2. Tick-borne encephalitis
        3. Rabies encephalitis
      3. APAC Encephalitis Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adult
      4. China
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      5. Korea
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      6. Japan
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      7. India
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      8. Australia
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      9. Singapore
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      10. Taiwan
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      11. South East Asia
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      12. Rest of Asia-Pacific
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
    4. Middle East and Africa
      1. Middle East and Africa Encephalitis Vaccines Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
      2. Middle East and Africa Encephalitis Vaccines Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Japanese encephalitis
        2. Tick-borne encephalitis
        3. Rabies encephalitis
      3. Middle East and Africa Encephalitis Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adult
      4. UAE
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      5. Turkey
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      6. Saudi Arabia
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      7. South Africa
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      8. Egypt
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      9. Nigeria
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      10. Rest of MEA
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
    5. LATAM
      1. LATAM Encephalitis Vaccines Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
      2. LATAM Encephalitis Vaccines Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Japanese encephalitis
        2. Tick-borne encephalitis
        3. Rabies encephalitis
      3. LATAM Encephalitis Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adult
      4. Brazil
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      5. Mexico
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      6. Argentina
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      7. Chile
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      8. Colombia
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
      9. Rest of LATAM
        1. Mouse brain-derived inactivated vaccine
        2. Cell culture-derived inactivated vaccine
        3. Cell culture-derived live attenuated vaccine
        4. Japanese encephalitis
        5. Tick-borne encephalitis
        6. Rabies encephalitis
        7. Children
        8. Adult
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.